Cutting edge:: In contrast to effector T cells, CD4+CD25+ FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death

被引:152
作者
Fritzsching, B
Oberle, N
Eberhardt, N
Quick, S
Haas, J
Wildemann, B
Krammer, PH
Suri-Payer, E
机构
[1] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany
关键词
D O I
10.4049/jimmunol.175.1.32
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) CD25(+) FoxP3(+) regulatory T cells (T-reg) suppress T cell function and protect rodents from autoimmune disease. Regulation of T-reg during an immune response is of major importance. Enhanced survival of T-reg is beneficial inautoimmunedisease, where as increased depletion by apoptosis is advantageous in cancer. We show here that freshly isolated FACS-sorted T-reg are highly sensitive toward CD95-mediated apoptosis, whereas other T cell populations are resistant to CD95-induced apoptosis shortly after isolation. In contrast, TCR restimulation of T-reg in vitro reg revealed a reduced sensitivity toward activation-induced cell death compared with CD4(+) CD25(-)T cells. Thus, the apoptosis phenotype of T is unique in comparison to reg other T cells, and this might be further explored for novel therapeutic modulations of Treg.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 28 条
[1]   ORGAN-SPECIFIC AUTOIMMUNITY [J].
BACH, JF .
IMMUNOLOGY TODAY, 1995, 16 (07) :353-355
[2]   Modulation of Fas-dependent apoptosis: A dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells [J].
Banz, A ;
Pontoux, C ;
Papiernik, M .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :750-757
[3]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[4]   Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death [J].
Chen, X ;
Murakami, T ;
Oppenheim, JJ ;
Howard, DMZ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :859-869
[5]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[6]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150
[7]   Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy [J].
Ehrenstein, MR ;
Evans, JG ;
Singh, A ;
Moore, S ;
Warnes, G ;
Isenberg, DA ;
Mauri, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :277-285
[8]   CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative [J].
Ghiringhelli, F ;
Larmonier, N ;
Schmitt, E ;
Parcellier, A ;
Cathelin, D ;
Garrido, C ;
Chauffert, B ;
Solary, E ;
Bonnotte, B ;
Martin, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :336-344
[9]   Activation-induced cell death in T cells [J].
Green, DR ;
Droin, N ;
Pinkoski, M .
IMMUNOLOGICAL REVIEWS, 2003, 193 (01) :70-81
[10]   Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo [J].
Grundström, S ;
Cederbom, L ;
Sundstedt, A ;
Scheipers, P ;
Ivars, F .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5008-5017